Home > Insider Trading > Filing (0001209191-15-054333)

Filing Details

Accession Number:: 0001209191-15-054333
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-17 18:04:08
Reporting Period:: 2015-06-15

Filing Date:: 2015-06-17
Accepted Time:: 2015-06-17 18:04:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1103021	Biodelivery Sciences International Inc	BDSI	Pharmaceutical Preparations (2834)	352089858

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1066040	Jr E Francis Odonnell	C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-06-15	4,105	$0.00	172,825	No	4	A	Direct
Common Stock	Disposition	2015-06-16	1,597	$7.97	171,228	No	4	S	Direct
Common Stock	Disposition	2015-06-16	20,000	$8.03	151,228	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of restricted stock units granted under the Registrant's Performance Long Term Incentive Plan.
The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
On June 16, 2015, the Reporting Person sold an aggregate of 1,597 shares of the Issuer's Common Stock at a weighted average price of $7.97. The highest sale price for the Common Stock was $8.07 per share and the lowest sale price was $7.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares of common stock were sold under a pre-planned 10b5-1 trading plan.
On June 16, 2015, the Reporting Person sold an aggregate of 20,000 shares of the Issuer's Common Stock at a weighted average price of $8.03. The highest sale price for the Common Stock was $8.19 per share and the lowest sale price was $7.87 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.